These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Growth factors in haematology: prophylactic versus interventional use. Boogaerts MA Eur J Cancer; 1994; 30A(2):238-43. PubMed ID: 7908820 [No Abstract] [Full Text] [Related]
5. [What are the treatment possibilities for myelodysplastic syndrome?]. von Wichert P Internist (Berl); 1995 Jan; 36(1):74-5. PubMed ID: 7883535 [No Abstract] [Full Text] [Related]
8. The role of erythropoietin and other growth factors in transfusion medicine. Klingemann HG; Shepherd JD; Eaves CJ; Eaves AC Transfus Med Rev; 1991 Jan; 5(1):33-47. PubMed ID: 1802275 [No Abstract] [Full Text] [Related]
10. The role of hematopoietic growth factors in the treatment of neoplastic diseases. St Onge J; Jacobson RJ Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737 [No Abstract] [Full Text] [Related]
11. Myelodysplasia: clinical and morphological aspects and treatment. Geary CG Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491 [No Abstract] [Full Text] [Related]
12. [Hematopoietic growth factors]. Fillet G Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118 [No Abstract] [Full Text] [Related]
13. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. Ganser A; Hoelzer D Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229 [No Abstract] [Full Text] [Related]